Shingles News and Research

RSS

Shingles (herpes zoster) is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox — the varicella-zoster virus. The first sign of shingles is often burning or tingling pain, or sometimes numbness or itch, in one particular location on only one side of the body.

Novavax's new bird flu vaccine could bolster the arsenal against a pandemic

The drug company Novavax has announced that it's experimental avian flu vaccine has proved to be both safe and effective in Phase I/IIa trials in humans.

20 Dec 2007

Shingles virus and vaccination

When a vaccine to prevent shingles was approved for use in 2006, the Food and Drug Administration recommended the vaccine for people age 60 and older who previously had chickenpox.

13 Dec 2007

Study results from Zolinza (vorinostat) in combination with bortezomib for multiple myeloma trial

Results from two investigational Phase I trials of ZOLINZA (vorinostat) in combination with bortezomib provide preliminary anti-tumor activity in patients with relapsed and/or refractory multiple myeloma.

10 Dec 2007

sLRP1-alpha provides relief from neuropathic pain

Injury to peripheral nerves (the causes of which include shingles, HIV-AIDS, toxins, alcoholism, repetitive motion disorders, surgery, and cancer) causes neuropathic pain, which differs from ordinary pain and is usually perceived as a steady burning, pins and needles, electric shock sensations, and/or tickling.

4 Dec 2007

New breast cancer screening guidelines

New guidelines from the American Cancer Society (ACS) recommend that women at very high risk for breast cancer receive magnetic resonance imaging (MRI) along with annual mammography, reports the October 2007 issue of Harvard Women's Health Watch .

27 Sep 2007

New understanding of how HSV-1 attacks cells

A team of University of Kentucky researchers has identified the roles that herpes simplex virus type 1 (HSV-1) proteins play during the invasion of cells and the formation of skin lesions known as cold sores and fever blisters.

17 Aug 2007

Vaccines approved by the FDA are at least a million times safer than the viruses that they prevent

For more than 200 years, vaccines have played an important role in the prevention of infectious diseases.

2 Aug 2007

Selenium supplements may do more harm than good

In a British trial examining the benefit of selenium supplements it has been found that in some cases the supplement can do more harm than good.

11 Jul 2007

Selenium supplements appear to increase risk of developing type 2 diabetes

A new analysis of data from a large national study found that people who took a 200 microgram selenium supplement each day for almost eight years had an increased risk of developing type 2 diabetes than those who took a placebo or dummy pill.

10 Jul 2007

Green light for first drug to treat fibromyalgia

Authorities in the United States have given approval for the first drug to treat the condition fibromyalgia.

25 Jun 2007

U.S. FDA approves Lyrica (pregabalin), the first drug to treat fibromyalgia

The U.S. Food and Drug Administration has approved Lyrica (pregabalin), the first drug to treat fibromyalgia, a disorder characterized by pain, fatigue and sleep problems.

23 Jun 2007

Discomfort and disability caused by shingles can be avoided

The painful, burning twinge and irritate skin that can be an early warning sign of shingles is often overlooked or misdiagnosed at the time when antiviral medications can be effected at shortening the outbreak.

23 Jun 2007

New infectious diseases blueprint for action

New vaccines are available to make significant gains against cervical cancer deaths and debilitating pain from shingles, but infectious diseases experts warn that their full potential will not be realized without changes in the way vaccines for adults and adolescents are promoted, financed, and delivered in the United States.

19 Jun 2007

Gabapentin reduces hot flashes in men receiving androgen deprivation therapy

North Central Cancer Treatment Group ( http://ncctg/ ) researchers based at Mayo Clinic ( http://www.mayo.edu/ ) in Rochester, Minn., have discovered that low doses of a drug used to prevent epileptic seizures and to treat nerve pain caused by shingles substantially reduces hot flashes in patients who are undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.

5 Jun 2007

Gene therapy provides hope for peripheral neuropathy

Researchers from the University of Pittsburgh School of Medicine report that they have successfully used gene therapy to block the pain response in an animal model of neuropathic pain, a type of chronic pain in people for which there are few effective treatments.

1 Jun 2007

Methods for treating lupus nephritis

Good patient information is essential for choosing the best treatment for the kidney disease lupus nephritis.

17 May 2007

Tai chi helps seniors avoid shingles

According to recent research the ancient Chinese martial art of Tai chi offers benefits beyond improving fitness and balance for older adults.

8 Apr 2007

Vaccines for measles-mumps-rubella and varicella are effective in extremely preterm infants

The study, which included 16 term and 16 extremely preterm (born before about 6 months of pregnancy) infants born between May 2002 and May 2005, is the first of its kind to examine the antibody levels of measles, mumps, rubella and varicella in this population before and after vaccination. It was published in this month's Pediatrics.

5 Mar 2007

GlaxoSmithKline issues update on US patent litigation regarding Valtrex

GlaxoSmithKline has issued an update on US patent litigation regarding Valtrex (valacyclovir), an antiviral drug used for the treatment and suppression of genital herpes, herpes zoster (shingles), and cold sores.

5 Feb 2007

Drug for shingles relieves spinal cord injury pain

Australian doctors have discovered that patients with spinal cord injuries with moderate to severe nerve pain, received relief from a drug usually given to alleviate diabetic nerve pain and the pain from shingles.

2 Dec 2006